During ECR 2023 we sponsored two Symposia with remarkable speakers.
Stay tuned, as we will make available soon the recordings of each of the Satelite Symposia.
Learn What’s New in Ultrasound Liver Analysis and in CT & MRI Screening and Follow-up!

Satellite Symposium (Ultrasound)

Date: Wednesday, March 1
Time: 11:30-12:30
Location: Room N

Title: Ultrasound Liver Analysis: What’s New
Subtitle: From Early Detection and Diagnosis to Treatment

The prevalence of diffuse liver disease is increasing and is now a worldwide problem. In addition to alcohol abuse or chronic hepatitis, other causes are emerging such as metabolic syndrome leading to a higher prevalence of fatty liver or liver-related diseases. The wide variety of these causes and their impact on the liver require the combination of conventional ultrasound with new advanced diagnostic techniques to provide adequate staging of the patient. This symposium will review the use and diagnostic performance of these techniques such as elastography for the quantification of liver stiffness, fibrosis using Shear wave technology (SWE), the new tissue attenuation parameter (ATI) for the quantification of steatosis or the inflammatory dispersion of liver tissue (SWD).

5 min | Introduction - Prof. Valérie Vilgrain, Paris, France (moderator)
20 min | Liver Shear Wave Elastography: SRU Consensus/Attenuation Imaging: Toward Standardization of Measurements - Dr. Giovanna Ferraioli, Pavia, Italy
20 min | Are We Ready for Global Ultrasound Analysis for Chronic Liver Diseases? - Dr. Marco Dioguardi Burgio, Paris, France
15 min | Summary and Perspective - Prof. Valérie Vilgrain , Paris, France (moderator)

Satellite Lunch Symposium (CT/MRI)

Date: Friday, March 3
Time: 12:30-13:30
Location: Room M

Title: CT & MRI Screening and Follow-up: What’s New
Subtitle: Clinical Experience with New AI Technologies

The European Union Council recently adopted a new approach to cancer screening, following the Commission's proposal to boost cancer prevention through early diagnosis. This is an important step in improving early detection throughout the EU, which is a fundamental goal of Europe's Beating Cancer Plan. The new strategy calls for gradually expanding population-based screening programs to include lung and prostate. *

This Symposium will concentrate on CT screening for lung cancer and MRI screening for prostate cancer.

  • Learn about Canon Medical's new CT scanner and why it is ideal for lung cancer screening.
  • Understand the evolution of AI in prostate MRI and its impact on clinical practice. How might AI help with prostate cancer screening by employing MRI as a supporting imaging modality?
5 min | Introduction - Prof. Stefan M. Niehues, (moderator), Berlin, Germany
20 min | Harnessing the Power of Automation in CT to Serve Screening Purposes - Dr. Russell Bull, Bournemouth, UK
20 min | AI in prostate MRI: current applications and perspectives (MRI)- Dr. Pierre Leyendecker, Strasbourg, France
15 min | Summary and perspective - Prof. Stefan M. Niehues, Berlin, Germany

* source:

Contact Us